Integrated Akt/PKB signaling in immunomodulation and its potential role in cancer immunotherapy.
about
Inhibition of CYFIP2 promotes gastric cancer cell proliferation and chemoresistance to 5-fluorouracil through activation of the Akt signaling pathway.Anticancer effect of curcumin inhibits cell growth through miR-21/PTEN/Akt pathway in breast cancer cell.Inactivation of PI3-K/Akt and reduction of SP1 and p65 expression increase the effect of solamargine on suppressing EP4 expression in human lung cancer cellsAcquired Resistance to Clinical Cancer Therapy: A Twist in Physiological Signaling.Advancing Immunotherapy in Metastatic Breast Cancer.Butyrate regulates the expression of inflammatory and chemotactic cytokines in human acute leukemic cells during apoptosis.Correlation of Apobec Mrna Expression with overall Survival and pd-l1 Expression in Urothelial Carcinoma.A novel reporter for real-time, quantitative imaging of AKT-directed K63-poly-ubiquitination in living cells.Role of mTOR Signaling in Tumor Microenvironment: An Overview
P2860
Q33599479-95E56BE5-2823-47C8-B675-24E8AD275BECQ33751048-C8738AF6-5E06-46D8-B721-81A0AA490FB7Q36393799-61F3FC5E-FE90-4C64-A0D0-B627B0016725Q38824661-8DEB9512-8EB6-4698-B09E-FAE5731E7008Q39324161-C6381193-68A2-4DC9-830D-D380E25A216EQ39715810-9542425B-44FD-4577-896D-258C1906C611Q42575965-37FAC7FC-30FB-465C-ABA6-5BF59B09A53DQ54974008-FB632620-E9BF-4D18-837F-407161B93916Q58766017-9B848E55-82F7-4254-AEB2-09B0E4E099BD
P2860
Integrated Akt/PKB signaling in immunomodulation and its potential role in cancer immunotherapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Integrated Akt/PKB signaling i ...... role in cancer immunotherapy.
@en
type
label
Integrated Akt/PKB signaling i ...... role in cancer immunotherapy.
@en
prefLabel
Integrated Akt/PKB signaling i ...... role in cancer immunotherapy.
@en
P2093
P2860
P356
P1476
Integrated Akt/PKB signaling i ...... role in cancer immunotherapy.
@en
P2093
Alfred Zippelius
Brian A Hemmings
Daniela Massi
Fengyuan Tang
Gongda Xue
Mario Mandalà
P2860
P356
10.1093/JNCI/DJV171
P407
P577
2015-06-11T00:00:00Z